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Osteocytes act as mechanosensors to control local
bone volume. However, their roles in the homeosta-
sis of remote organs are largely unknown. We show
that ablation of osteocytes in mice (osteocyte-less
[OL] mice) leads to severe lymphopenia, due to lack
of lymphoid-supporting stroma in both the bone
marrow and thymus, and complete loss of white
adipose tissues. These effects were reversed when
osteocytes were replenished within the bone. In
contrast, neither in vivo supply of T cell progenitors
and humoral factors via shared circulation with a
normal parabiotic partner nor ablation of specific
hypothalamic nuclei rescued thymic atrophy and fat
loss in OL mice. Furthermore, ablation of the hypo-
thalamus in OL mice led to hepatic steatosis, which
was rescued by parabiosis with normal mice. Our
results define a role for osteocytes as critical regula-
tors of lymphopoiesis and fat metabolism and sug-
gest that bone acts as a central regulator of multiple
organs.
INTRODUCTION
The bone is a sensory organ consisting of osteocytes and oste-
oblasts. Osteocytes comprise more than 90% of all bone cells
and form a comprehensive network throughout skeletal tissues.
Osteocytes contribute to bone homeostasis by converting me-
chanical stress to biological signals; hence, the major players
in bone turnover, osteoblasts and osteoclasts, are regulated
locally on the bone surface (Bonewald, 2011; Klein-Nulend
et al., 2013). Reduced mechanical stress to the bones of astro-
nauts or bedridden patients leads to rapid progression of osteo-
porosis and impaired immunity (Belavy´ et al., 2011; Crucian and
Sams, 2009; Gue´guinou et al., 2009; Lang et al., 2004). However,
it remains to be elucidated whether osteocytes are also critical
for homeostasis of the immune system and even other organs.
Here we address this issue using a mouse model in which tar-
geted ablation of osteocytes induces osteoporosis with defec-
tive mechanotransduction (Tatsumi et al., 2007).Cell MRESULTS
Osteocyte Ablation Caused Reversible Lymphopenia
and Lymphoid Organ Atrophy
We first confirmed that local microgravity on the hind limbs dur-
ing mouse tail suspension system, which is known to induce
local bone loss (Globus et al., 1984), suppressed the osteocyte
network formation in the bone and reduced the number of lym-
phocytes in the bone marrow (BM) of unloaded bone but not in
the systemic circulation (Figures S1A–S1D). However, the he-
matopoietic phenotype in this system could not be due to the
decreased stimulatory signals to osteocyte network by micro-
gravity alone, but other factors could be responsible as well,
e.g., less blood flow. To directly address the question of whether
the osteocyte network is indispensable not only for the bone but
also for other organs, we utilized transgenic (Tg) mouse model
with targeted expression of diphtheria toxin receptor (DTR) un-
der the promoter of dentin matrix protein-1 (DMP-1) (Tatsumi
et al., 2007). Fifteen-week-old wild-type (WT) and Tg littermate
mice were injected with a single dose of diphtheria toxin (DT).
The osteocyte-less (OL) mice showed a comparable lacunoca-
nalicular interstitial fluid space with WT mice, and there was a
marked reduction in neuron-like osteocyte network formed by
projections at 3 weeks (Figures 1A, S1E, and S1F). Importantly,
osteocytes seemed to be damaged in terms of reduced nuclear
size, but they were not depleted in this experiment. The term
‘‘OL’’ in this study is defined as the condition wherein some
osteocytes are killed and ablated while others are tentatively
compromised. The body weight declined steadily during the
3 weeks following DT injection (27.1 ± 2.0 g and 20.8 ± 1.5 g
for WT and OL mice, respectively; n = 10–11, p < 0.05). Periph-
eral blood leukocyte count was significantly reduced in OL
mice due to severe B and T lymphopenia (Figure 1B). A recent
report has shown that the deletion of Gsa specifically in osteo-
cytes strongly enhanced myelopoiesis due to the excess
production of granulocyte colony-stimulating factor (G-CSF),
presumably from osteocytes (Fulzele et al., 2013). However,
OL mice showed no alteration in myelopoiesis, which implies
that G-CSF from osteocytes during steady state may not be
indispensable. Drastic thymic atrophy with reduction of thymo-
cytes by 90% was also found in OL mice (Figure 1C), as well
as splenic atrophy (Figure 1D). These were not due to direct
damage by DT in view of the specific expression of DMP-1/
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ure 1E), presumably by embedding of intact osteoblasts then
terminal differentiation to new osteocytes or from contribution
of osteocytes that recovered from the damage. Consequently,
lymphopenia and lymphoid organ atrophy were completely
normalized (Figures 1F–1H). These results suggest a functional
communication between the bone and lymphoid organs.
Impaired B Lymphopoiesis in OL Mice Caused by
Depletion of Lymphoid-Specific Stroma in Bone Marrow
Wenext evaluated lymphopoiesis in the BM, which is the primary
organ for B-lymphogenesis. Although BM cellularity decreased
only slightly, B220+/IgM immature B cell fraction wasmarkedly
depleted in OL mice (Figures 2A and 2B). Hematopoietic stem
cells (HSCs) were not affected in OL mice because the number
of lineage/IL-7Ra/Sca-1+/c-kit+ cells was normal (Fig-
ure S2A). Furthermore, in the competitive repopulation assay,
the chimerism of BM cells from OL mice was comparable to
those from control mice (Figures S2B and S2C), which indicated
that the lymphoid-specific defect in OLmice was ascribed to the
hematopoietic microenvironment, but not to HSCs. While com-
mon lymphoid progenitors (CLP; lineage/IL-7Ra+/Sca-1+/c-
kit+) decreased only modestly, pro-B (B220+/IgM/CD43+)
and pre-B (B220+/IgM/CD43) cells were markedly reduced
in numbers (Figures 2C–2E). Results of colony-forming unit
(cfu) assays were consistent with a lymphoid-specific defect,
wherein the number of cfu-pre-B was greatly reduced in OL
BM (Figure 2F) while myeloid cfu-granulocyte/macrophage
(GM) was normal (Figure 2G). Thus, the marked decrease in B
cells in the BM of OL mice took place at an early important
step during B-lymphogenesis when the support by the specific
stroma was required (Hardy et al., 1991). A key factor for B-lym-
phopoiesis, CXCL12 (Egawa et al., 2001), was decreased at
neither the protein nor the mRNA level in OL mice BM (data not
shown). Furthermore, to examine whether the impairment of
B-lymphopoiesis was due to the decrease in osteocyte-secreted
factors, we culturedWTBMcells on the layer of osteolineage cell
lines, namely ST2 (mesenchymal stromal cells), MC3T3-E1
(osteoblastic cells), and MLO-Y4 (osteocytic cells). The results
showed that B-lymphoid progenitor cells (B220+IgM cells)
were well maintained on the ST2 but not on the MC3T3-E1 and
MLO-Y4 (Figure S2D). These data suggested that neither osteo-
cyte-secreted molecules nor direct contact with osteocytes may
be essential for the maintenance of B-lymphogenesis.
To investigate BM stromal cell function, we performed long-
term BM cultures that specifically support B-lymphopoiesis
(B-LTBMC) and myelopoiesis (M-LTBMC). Under B-LTBMC
condition, BM cells from normal mice formed a stromal layer
and supported the production of small lymphoid-appearing
B220+ cells. Strikingly, OL BM cultures did not produce smallFigure 1. Osteocyte Ablation Causes Reversible Lymphopenia and Lym
(A) Immunofluorescence staining of femoral cortical bone of WT (left) and OL (right
3100.
(B) Peripheral blood cells were analyzed for surface expression of B and T lymph
(C and D) Gross appearance (top panels) and hematoxylin and eosin (H&E)-sta
(bottom panels, n = 7–9) of WT or OL thymus (C) and spleen (D).
(E–H) Representative femoral sections of WT or OLmice at 100 days following DT
osteocyte regeneration (E, original magnification3100). Peripheral blood cell cou
(B)–(D) and (F)–(H) are shown as mean values ± SEM. *p < 0.05, **p < 0.01, ***p
Cell Mlymphoid-like cells but instead generated similar numbers of
macrophages throughout the 6 week culture period (Figures
2H and 2I). In contrast, cultures from OL BM grown under
M-LTBMC conditions were indistinguishable from those of
normal mice (Figures S2E and S2F). The control adherent layer
grown under B-LTBMC conditions contained approximately
30%–40% of nonhematopoietic stromal cells (CD45F4/80
and CD45VCAM-1+), and the rest were macrophages
(CD45+F4/80+). Noticeably, the vast majority of adherent cells
in OL BM cultures were macrophages, and the nonhemato-
poietic stromal fraction was almost depleted (Figure 2J). Under
M-LTBMC conditions, nonhematopoietic stromal cells were
comparable between control and OL cultures (Figure S2G).
Mesenchymal progenitors, as assessed by fibroblast colony-
forming unit (cfu-F) assay, were normal in OL BM (Figure 2K),
and the switch from M- into B-LTBMC conditions gave rise to
B cells together with normal stromal components (Figures
S2H–S2J). These results suggested that the severe impairment
of B-lymphopoiesis in OL BM was due to a depletion of
B-lymphoid-specific stromal cells.
Osteocyte Ablation Caused Thymocyte Depletion due to
Defective Microenvironment
The thymus, another primary lymphoid organ for T cells, was
next investigated in OL mice. Owing to a marked reduction in
cellularity of the thymus, the absolute cell numbers were reduced
in all four CD4/CD8 fractions, with a remarkable decrease in the
percentage of the double-positive fraction (Figure 3A). This
finding seems to be caused by a specific deletion of osteocytes,
since targeted ablation of osteoblasts is not associated with
alteration of the thymus (Visnjic et al., 2004). The absolute
number of pro-T cells (CD3/CD4/CD8/c-kit+/CD25) in
the thymuswas greatly reduced (Figure 3B). Consideringmodest
change only in CLP in the BM (Figure 2C), it would be reasonable
to assume that the T cell progenitors supplied to the thymus
could not proliferate because of environmental defect in OL
thymus. Immunohistochemical staining of thymic epithelial cells
(TEC) with keratin5 (K5) and keratin8 (K8) antibodies demon-
strated that K8+ cortical epithelial area was drastically
decreased, while K5+ medullary epithelial area was relatively
preserved (Figure 3C). Likewise, K8+ cortical thymic epithelial
meshwork structure became sparse (Figure 3C), but that of
K5+ medullary epithelium appeared normal (Figure S3A). Supply
of T cell progenitors from OL BM into irradiated WT mice by BM
transplantation showed a normal reconstitution of thymocytes
with normal distribution of K5+/K8+ epithelial cells (data not
shown). Reciprocal transplantation was not assessed, since
OL mice were too fragile as recipients. Moreover, the phenotype
was transient for evaluation of T cell engraftment. Thus, we
further examined OL thymic environment by using a parabioticphoid Organ Atrophy
) mice. Images of CD44 and DAPI staining were merged. Original magnification
ocyte or myeloid markers (n = 6–7).
ined sections (middle panels, original magnification 34), and organ cellularity
administration that showed recovery of osteocyte network formation alongwith
nts (F), thymus (G), and spleen (H) cellularity were also restored (n = 4). Data in
< 0.001. See also Figure S1.
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Figure 2. Impaired B-Lymphopoiesis in OL Mice due to Depletion of Lymphoid-Specific Stroma in Bone Marrow
(A) WT versus OL mouse BM cellularity (n = 8–9).
(B–E) BM nucleated cells were analyzed for surface expression of CLP (C, n = 10) or markers of different stages of B lymphocyte progenitors (B, D, and E, n = 3–4).
(F and G) Frequency of cfu-pre-B (n = 5) and cfu-GM (n = 7–8).
(H) In B-LTBMC, OL mouse BM produced larger floating cells than those from WT BM. Original magnification 340. The inset shows May-Giemsa-stained
cytospin preparations.
(I) Percentages of B220+ cells among floating cells in B-LTBMC at the indicated periods after initiation of cultures (n = 3–4).
(J) FACS analysis of adherent cells in B-LTBMC. Red-gated CD45 stromal cells were greatly reduced in OL mouse B-LTBMC (n = 4).
(K) The number of cfu-fibroblast (cfu-F) in WT and OL mice BM (n = 3). Data in (A), (C)–(G), (I), and (K) are shown as mean values ± SEM. *p < 0.05, **p < 0.01. See
also Figure S2.
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Figure 3. Osteocyte Ablation Causes Thymocyte Depletion due to Defective Microenviroment
(A) FACS analysis of surface expression of T cell markers in WT versus OL mice thymus (n = 6).
(B) Number of pro-T cells in the thymus (n = 6).
(C) Immunofluorescence staining of K5 (red), K8 (green), and DAPI (blue) in the thymus. Upper panel, original magnification 34. Lower panel: cortical thymic
epithelial cells (CTEC) stained with K8 were merged with DAPI. Magnifications 3100.
(D and E) Experimental design of parabiosis. A CD45.2WT or Tg mouse was joined with a CD45.1 WTmouse and maintained for 5–6 weeks (E, n = 7). At 3 weeks
following DT injection, thymic cellularity was quantified (D). Nucleated cells were isolated from the thymus of DT-injected CD45.1 WT and CD45.2 Tg (OL)
parabiotic pairs and analyzed for T cell marker by FACS (E). Representative red plots of thymocytes originated from aCD45.2 OLmouse, and blue plots originated
from a CD45.1 WT mouse (n = 7). Data in (B) and (D) are shown as mean values ± SEM. **p < 0.01, ***p < 0.001. See also Figure S3.
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Remote Organ Control by Osteocytesmodel. The CD45.1 congenic WT mice were surgically joined
with CD45.2 WT or TGmice, and it was confirmed that the blood
was equally shared (Figure S3B). After parabiotic pairs were
maintained for 5–6 weeks after surgery, DT was injected in
each mouse at 15 weeks of age. Three weeks after osteocyte
depletion, the thymus was evaluated. In CD45.1 WT and
CD45.2 WT parabionts, a certain population of thymocytes
showed normal differentiation in the parabiotic partners (Fig-
ure S3C). Importantly, the sharing of circulation with normal
mice did not rescue thymic atrophy in OL mice (Figure 3D).
Consistent with our hypothesis that the defect in T cell develop-
ment was due to impairedmicroenvironment in the thymus, T cell
progenitors derived from OL mice differentiated normally in the
thymus of WT partner, whereas those from WT mice failed to
differentiate in the thymus of OL partner (Figure 3E). These re-
sults indicate that in the absence of normal osteocyte network
within the bone, microenvironment of the thymus is impaired,
and the phenotype is not rescued by humoral factors from
normal partners in the parabiotic experimental system.
Osteocytes Regulated Fat Metabolism
In our study, the OL mice showed a progressive decrease in
body weight in the course of few weeks after DT injection, and
the weight gradually recovered along with the replenishment of
osteocytes (Figure S4A). The OL mice lacked visible white adi-
pose tissue (WAT) including subcutaneous, mesenteric, and
retroperitoneal fat tissue and epididymal fat pad mass (Fig-
ure 4A). Plasma leptin level was decreased in association with
fat loss (Figure S4B). This phenotype reminded us of human lip-
odystrophy (Garg, 2004; Huang-Doran et al., 2010; Simha and
Garg, 2006); however, representative lipodystrophy-related
genes were not affected in OL mice (Figure S4C). Despite a sig-
nificant decrease in osteocalcin (Figure S4D), which has been re-
ported to regulate insulin secretion in the pancreas and glucose
metabolism (Ferron et al., 2010; Fulzele et al., 2010), OL mice
were not found to be diabetic (Figure S4E) in contrast to cases
of human lipodystrophy. To examine whether lipid was
consumed by the increased energy demand, energy expenditure
was assessed during the period of body weight loss, but it was
rather decreased in OL mice (Figure S4F). These results suggest
that lipid is not used, but is just lost after the ablation of osteocyte
network. As there was a nonsignificant but slight trend of
decrease in food intake (Figure S4G), we tested whether fat
loss in OL mice could be rescued by high-fat diet. However,
the results still showed the depletion of WAT and prevention of
fatty liver (Figure S4H). Furthermore, it was unlikely that the fat/
weight loss in OL mice was caused by digestive abnormalities
since they had normal excrement with no signs of diarrhea or
hematochezia. Endocrine malfunctions, such as hyperthyroid-
ism and excess catecholamine secretion, were not possible
causes either, in view of the absence of increase in heart rate
(data not shown). In addition, the plasma concentration of
corticosterone, which is secreted under a stressful condition
and causes lipolysis or thymic atrophy, was not increased signif-
icantly in OLmice (Figure S4I). Because the sharing of circulation
with normal mice by parabiosis did not rescue the fat loss
induced by osteocyte depletion or cause any changes in the
normal partner (data not shown), fat/weight loss could not be
attributed to the humoral mechanism. These results led us to754 Cell Metabolism 18, 749–758, November 5, 2013 ª2013 Elsevierspeculate that the integrity of osteocyte network is required for
fat maintenance and raise the possibility that osteocyte network
within the bone controls fat metabolism through the central
nervous system (CNS).
It is recognized that certain areas of the brain, such as the
ventromedial hypothalamic nucleus (VMH) and arcuate nucleus
(ARC), also control bone metabolism via the sympathetic ner-
vous system in response to leptin signaling (Elefteriou et al.,
2005; Takeda et al., 2002). Thus, we hypothesized that osteo-
cytes might cooperate with the CNS to regulate fat metabolism.
To test this, the VMHwas ablated before osteocyte depletion. As
expected, VMH ablation induced drastic obesity with high
amount of WAT in both WT and Tg mice. After DT injection,
thymic atrophy and peripheral WAT loss occurred in Tg mice
irrespective of VMH ablation (Figures S4J and S4K). Strikingly,
the liver of OL mice with ablated VMH became markedly
enlarged andwhitish in color due to severe fat accumulation (Fig-
ure 4B). This model of aberrant fat distribution recapitulates the
phenotype of the human generalized lipodystrophy with hepatic
steatosis (Garg, 2004). The sharing of circulation between VMH-
ablatedOLmice and normal partners by parabiosis, although the
recovery of peripheral WAT loss was not observed (data not
shown), rescued the severe accumulation of fat in the liver (Fig-
ure 4C), suggestive of impaired fat clearance machinery in the
liver. The expression of sterol regulatory element-binding pro-
tein-1c (SREBP1c) (Horton et al., 2002), a key lipogenic activator
in nonalcoholic steatohepatitis (NASH), was markedly sup-
pressed in VMH-ablated OL mice (Figure 4D), perhaps due to a
negative feedback mechanism. The Fbxw7 (Onoyama et al.,
2011), an ubiquitin ligase that promotes the degradation of
SREBP1c, was not critically affected by VMH ablation or osteo-
cyte depletion. Importantly, the expression of microsomal
triglyceride transfer protein (MTP), a main player in the fat clear-
ance from the liver, and apoB (Lette´ron et al., 2003; Shindo et al.,
2010) was increased by VMH ablation, most likely to dispose an
increased fat intake, but the increase was cancelled by the
depletion of osteocytes (Figure 4D). Ablation of ARC also
induced obesity, and ARC-ablated OL mice exhibited fat loss
and hepatic steatosis (data not shown). The expression of fat
clearance genes in the liver, such as MTP and apoB, was sup-
pressed by ARC ablation (Figure 4D). Although each part of the
brain may affect fat clearance from the liver through different
mechanisms, a large amount of fat that flows out of peripheral
WAT following osteocyte depletion may accumulate in the liver,
where the fat clearance system is impaired by the ablation of
hypothalamic nuclei or osteocytic network. Levels of plasma
free fatty acid (FFA) and triglyceride were severely decreased
by osteocyte depletion; however, these levels were restored by
the ablation of the VMH, perhaps in association with fat accumu-
lation in the liver (Figure S4L).
These data suggest that osteocytes may control fat mainte-
nance in the whole body, including the circulation, and the hypo-
thalamus may cooperate with this system by regulating the liver
function.
Bone Environment after Osteocyte Depletion
This OL mouse model is known to induce not only osteocyte
ablation, but also osteoclast activation (Tatsumi et al., 2007).





Figure 4. Osteocytes Regulate Fat Metabolism
(A) Gross appearance of subcutaneous, mesenteric, and epididymal fat tissues of WT and OLmice. Epididymal fat pad weight to body weight ratio in WT and OL
mice (n = 3). n.d.: not detectable.
(B) Gross appearance, H&E-stained sections and oil red O-stained sections of the liver from the indicated mice (original magnification 310).
(C) Gross appearance, H&E-stained sections and oil red O-stained sections of the liver of indicated parabiotic pairs (original magnification 310).
(D) Real-time PCR analysis of SREBP1c, Fbxw7,MTP, and apoBmRNA in the livers of the indicated mice. Expression levels were normalized for b-actin (n = 4–5).
(E) Schematic illustration of ‘‘Bone as a central regulator of multiple organs.’’ Data in (A) and (D) are shown as mean values ± SEM. *p < 0.05, **p < 0.01, ***p <
0.001. See also Figure S4.
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Remote Organ Control by Osteocytesactivation of osteoclasts or inflammatory cytokines as triggered
by damaged osteocytes might affect lymphopoiesis and fat
metabolism. To address this concern, we examined the bone
environment. As previously described (Tatsumi et al., 2007), the
RANKL mRNA and the number of osteoclasts were slightly
elevated in OL mice (Figures S4M and S4N). However, bone re-
modeling rate, as assessed by the calcein double labeling, did
not differ between WT and OL mice (Figure S4O). In addition,
ovariectomy, known as a model of heightened bone remodeling,
augments B-lymphopoiesis and body weight according to the
literature (Chen and Heiman, 2001; Erben et al., 1998; Wronski
et al., 1986). Conversely, as amodel of lowered bone remodeling,
we assessed aged Tgmice (48–54 weeks old). After DT injection,
a similar phenotype as in 18-week-old mice was observed,
including the drastic decrease of lymphoid progenitors and, to
a lesser extent, fat loss (Figure S4P). Next, the level of inflamma-
tory cytokines in the plasma and BM extracellular fluid was
measured, and there was no difference between WT and OL
mice (Figures S4Q and S4R). Although the effect of osteocyte
ablation on lymphopoiesis and fat metabolism could be partially
influenced by the rate of bone remodeling or by the minor sub-
populations of DMP-1-expressing cells in the thymic stroma or
brain, these results suggested that the majority of the phenotype
in OL mice was a direct result of the lack of osteocyte function.
DISCUSSION
This study reveals unexpected roles for bone osteocytes. The re-
sults suggest that bone governs lymphopoiesis through the
regulation of the microenvironment in primary lymphoid organs
and also controls fat metabolism throughout the body in cooper-
ation with the brain (Figure 4E). Considering the reduced number
of lymphocytes in the marrow of unloaded bone (Figures S1A–
S1D), signals in the osteocyte network activated by gravity
may be indispensable for the maintenance of multiple distant
organs.
Although the signaling mechanism that links the bone with
lymphoid organs or fat tissues remains to be elucidated, one
potential candidate is the nervous system, given our previous
observation of a rapidly progressive lymphopenia due to a
lymphoid-specific stromal defect in UDP-galactose ceramide
galactosyltransferase-deficient (cgt/) mice (Katayama and
Frenette, 2003). The key enzyme for synthesis of major glyco-
lipids in myelin sheath is cgt. The fact that cgt/ mice display
impaired neural conduction suggests that stromal-dependent
lymphopoiesis is regulated by the nervous system. To examine
whether osteocytes affect lymphopoiesis and fat metabolism
through the nervous system, we performed chemical and surgi-
cal denervation such as adrenergic nerve destruction by 6-hy-
droxydopamine treatment, interception of the vagus nerve that
innervates the thymus, or disruption of afferent nerves by capsa-
icin treatment before osteocyte depletion. However, none of
these interventions rescued the defect in OL mice (data not
shown). In addition, nerve conduction velocity was normal in
OL mice (data not shown). Further studies on humoral factors
that cannot be supplied by parabiosis, as well as interaction of
bone with the nervous system, may be necessary.
Osteoblasts are now thought to be key players not only in
bone homeostasis, but also in the maintenance of other organs756 Cell Metabolism 18, 749–758, November 5, 2013 ª2013 Elsevier(Karsenty and Ferron, 2012). Several genetic models of osteo-
blast-specific depletion by using osteocalcin promoter have
been published to investigate the role of osteoblasts in vivo.
However, osteocalcin promoter has high activity in differenti-
ated osteoblasts but is also active in osteocytes, which termi-
nally differentiate from osteoblasts (O’Brien et al., 2004). In a
model, inducible ablation of osteocalcin-expressing cells re-
sulted in the alteration of both glucose and fat metabolisms
(Yoshikawa et al., 2011). Interestingly, the administration of
recombinant osteocalcin in this model reversed many of the
abnormalities in glucose homeostasis but not the decreased
fat in the gonad and liver. Together with our observations on
OL mice, in which glucose metabolism does not appear to be
altered but fat loss is prominent, osteoblasts and osteocytes
may preferentially regulate glucose and fat metabolisms,
respectively.
Our current findings imply that signals in the osteocyte
network induced by the sensation of gravity are important for
the maintenance of whole-organ homeostasis and systemic
health. Although the brain has been recognized as the central
control of all organs, this study suggests that bone may also
act as a central regulator of multiple organs.
EXPERIMENTAL PROCEDURES
Mice
The DMP-1 DTR Tg mice (Tatsumi et al., 2007) were backcrossed for more
than nine generations into C57BL/6 background before use. Fifteen-week-
old WT and Tg littermate mice were injected with a single dose of DT
(20 mg/kg, i.p., Sigma-Aldrich Japan, Tokyo), and then samples were
harvested and examined 3 weeks later (at 18 weeks) unless otherwise indi-
cated. The C57BL/6-CD45.1 congenic mice were purchased from The Jack-
son Laboratory (Bar Harbor, ME). All mice were fed a normal diet except the
high-fat diet experiment for Figure S4H. All animal experiments were
approved by the Institutional Animal Care and Use Committee and were
carried out according to the Kobe University Animal Experimentation
Regulations.
Flow Cytometry
Antibodies: biotin mouse lineage panel, PE-anti-B220 (clone RA3-6B2), PE-
anti-CD3ε (clone 145-2C11), PE-anti-c-kit (clone 2B8), FITC-anti-Sca-1 (clone
E13-161.7), FITC-anti-CD45.2 (104), biotin-anti-CD45.1 (A20), PE-anti-CD4
(GK1.5), FITC-anti-CD8 (53-6.7), and biotin-anti-CD25 (7D4) were from BD
PharMingen (San Diego, CA). FITC-anti-IgM was from Southern Biotech
(Birmingham, AL). PE-Cy5-anti-IL-7R (A7R34), APC-anti-CD45.2 (104),
biotin-anti-F4/80 (BM8), biotin-anti-VCAM-1 (429), APC-streptavidin, and
PE-streptavidin were from eBioscience (San Diego, CA). Cells were
suspended in PBS/0.5% BSA/2 mM EDTA. Adherent cells in long-term BM
cultures were stained after trypsinization and were analyzed using high-side
scatter gating as previously described (Katayama and Frenette, 2003). Cell
analyses were performed on a FACSCalibur flow cytometer with CellQuest
software (Becton Dickinson) and MoFlo XDP flow cytometer with summit
software (Beckman Coulter).
Cell Isolation and cfu Assays
BM cells were harvested by flushing the femora aseptically in RPMI1640, and
single-cell suspension was obtained by gentle aspiration several times. The
suspension volume was measured with a graduated pipette. The cfu-GM
assays were done by inoculating BM mononuclear cells into Methocult
M3534 media (StemCell Technologies) according to manufacturer’s recom-
mendation. The IL-7-dependent cfu-pre-B assays were done using Methocult
M3630, and cfu-F cells were assayed in MesenCult Basal Medium supple-
mented with Mesenchymal Stem Cell Stimulatory Supplement (STEMCELL
Technologies).Inc.
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ST2 (mesenchymal stromal cells), MC3T3-E1 (osteoblastic cells), andMLO-Y4
(osteocytic cells) were grown to semiconfluence in aMEM supplemented with
10% fetal bovine serum (FBS) in six-well culture plates. The medium was
removed, and 1 3 106 adherent cell-depleted BM samples from 7-week-old
WT mice were cultured with or without the osteolineage cell layer in
RPMI1640 supplemented with 5% FBS and 5 3 105 M 2-mercaptoethanol
at 37C for 4 days. Floating cells were analyzed for B220/IgM expression by
flow cytometry.
Long-Term Bone Marrow Cultures
The B- and M-LTBMC were performed exactly as previously described (Ka-
tayama and Frenette, 2003).
Generation of Chimeric Mice
Chimeric mice were generated by injection of 5 3 106 WT or OL mouse
(CD45.2) BM nucleated cells (BMNCs) into lethally irradiated (14 Gy, split
dose) CD45.1 mice. Reconstitution by donor cells was confirmed in all mice
by blood cell count and CD45.1/CD45.2 chimerism of peripheral blood leuko-
cytes monthly. For competitive reconstitution, 1 3 106 BMNCs from DT-in-
jected WT or OL mice (CD45.2) were injected together with 1 3 106 fresh
BM competitor cells (CD45.1) into lethally irradiated (14 Gy, split dose)
C57BL/6-CD45.1 congenic mice. Blood was harvestedmonthly from recipient
mice, and the expressions of CD45.1 and CD45.2 were assessed by flow
cytometry.
Parabiosis
Pairs of 9- to 10-week-old mice were anaesthetized and prepared for surgery.
Mirror image incisions at the left and right flanks, respectively, were made
through the skin. The skin of the adjacent parabiont was sutured together.
Cross-circulation was determined in a subset of parabiotic pairs by measuring
the frequency of blood cells from one partner (CD45.1) in the blood of the other
partner (CD45.2). Each mouse, including WT partner, was injected with DT
5–6 weeks after the surgery (at 15 weeks of age) and then euthanized 3 weeks
after DT injection. Blood chimerism at the time of euthanization was typically
between 40% and 60%.
Histological Analysis
Liver tissue was frozen in OCT compound (Sakura Fine Technical, Tokyo,
Japan) and stained with H&E and oil red O according to standard procedures.
Femoral bones were fixed overnight in 4% paraformaldehyde (PFA), frozen in
OCT compound, sectioned and stained for TRAP with TRAP/ALP Stain Kit
(Wako, Tokyo, Japan). Histological staining to visualize bone interstitial fluid
space using FITC was performed as described (Ciani et al., 2009). Bone label-
ing with peritoneal injection of calcein (20 mg/kg body weight; Dojinwako,
Tokyo, Japan) was performed at 5 and 2 days before death in mice used for
histomorphometry. The fluorescent signal derived from calcein labeling was
analyzed using LSM510 confocal laser scanning (CLS) microscopy system
(Carl Zeiss, Oberkochen, Germany).
Immunofluorescence Microscopy
Femoral bones were decalcified in 10% EDTA (pH 7.4) for 2 weeks, snap-
frozen in liquid nitrogen-chilled hexane, and sectioned at 10 mm thickness.
Sections were fixed with 4% PFA for 10 min, stained with anti-CD44 (BD Phar-
Mingen) followed by donkey Alexa-488-anti-rat IgG (Invitrogen, Carlsbad,
CA), and mounted in Vectashield Mounting Medium with 4,6-diamidino-2-
phenylindole (DAPI) (Vector Laboratories, Burlingame, CA). For phalloidin
staining, the sections were stained with Alexa-488-conjugated phalloidin
(Life Technologies Japan, Tokyo, Japan) and mounted with Vectashield
Mounting Medium with DAPI. Images were captured using LSM510 CLS mi-
croscopy system (Carl Zeiss). Thymic cryosections (5 mm) were fixed with 4%
PFA and stained with anti-mouse keratin 5 (Troma-1; Developmental Studies
Hybridoma Bank, University of Iowa, Iowa City, IA) and anti-keratin 8 (Cova-
nce Research Products, Berkeley, CA). Goat Alexa-488-anti-rat IgG and
goat Alexa-555-anti-rabbit IgG (Invitrogen) were used as secondary anti-
bodies. Images were captured using KEYENCE BZ-9000 fluorescent micro-
scope (Keyence, Osaka, Japan).Cell MRNA Extraction and Q-PCR
Total RNA was extracted from BMNCs using TRIzol solution (Invitrogen). The
bone carcass and other tissues were then immersed in liquid nitrogen and
pulverized into powder followed by RNA extraction with TRIzol. Total RNA
(2 mg) was treated with DNaseI (Invitrogen) and reverse transcribed using
first-strand cDNA synthesis with random primers (Promega, Madison, WI).
The Q-PCR was performed using SYBRGreen (Life Technologies Japan) on
LightCycler 480 System (Roche Diagnostics, Mannheim, Germany). Primers
used are listed in Table S1. All experiments were done in triplicate and normal-
ized to b-actin.
Pharmacological Disruption of Neurons or CNS
Ablation of VMH and ARC was done as described elsewhere (Takeda et al.,
2002). Briefly, to ablate VMH, 4-week-old mice were given a single intraperito-
neal injection with gold thioglucose (GTG) (0.5 mg/g of body weight, Research
Diagnostics, Inc.). To ablate ARC, 2-day-old C57BL/6 pups were given daily
subcutaneous injections of monosodium glutamate (MSG) (2 mg/g, Sigma-
Aldrich Japan) for 9 days. DT was injected at the age of 15 weeks.
Metabolic Studies
The energy expendituremeasurements were obtained using an eight-chamber
Oxymax system (Columbus Instruments, Columbus, OH). After 5 days accli-
mation to the apparatus, data for 24 hrmeasurement were exported toComma
Separated Value (CSV) files and analyzed as recommended by manufacturer.
Plasma leptin, plasma insulin, and osteocalcin concentrations in the plasma
and BMextracellular fluid (BMEF; obtained as previously described [Katayama
et al., 2006]) were measured with ELISA kits (BioVendor Candler, NC; Shi-
bayagi, Gunma, Japan; Biomedical Technologies, Inc., Stoughton, MA,
respectively). Plasma corticosterone levels were determined by liquid chroma-
tography-tandem mass spectrometry (LC-MS/MS). Plasma FFA and triglycer-
ide concentrations were measured with NEFA C test and Triglyceride E test
(Wako), respectively. Blood glucose levels were determined by glucose oxi-
dase method using Glutest Sensor Neo (Sanwa Kagaku, Kyoto, Japan).
Measurement of Inflammatory Cytokines
The levels of cytokines (TNF-a, IL-12p70, IL-6, IFN-g, IL-10, MCP-1, and IL-1b)
in the plasma and BMEF from WT and OL mice were quantitated using a
mouse inflammation cytometric bead array (CBA) kit (BD Biosciences) and
mouse IL-1b FlowCytomix (eBioscience), according to the manufacturer’s in-
structions. Data were acquired with a FACSCan flow cytometer (Becton Dick-
inson) and analyzed with BD CBA Software (BD Biosciences).
Statistical Analysis
All values were given as mean ± SEM. Comparisons between groups were
made by Student’s t test.
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